NSC vs RANI · P/E 18, rev $6.46B vs rev $3.4M
Norfolk Southern Corporation (NSC) versus Rani Therapeutics Holdings Inc (RANI) — a side-by-side from cached financials, not a winner call.
Norfolk Southern Corporation (NSC) is a railroads company listed on US.
Rani Therapeutics Holdings Inc (RANI) is a biotechnology company listed on US.
Latest reported NSC revenue for 2026-06-30 was $6.46B. Net income was $1.28B. NSC currently screens at market cap $60.10B and trailing P/E 18.2.
Latest reported RANI revenue for 2026-06-30 was $3.4M. Net income was -$14.4M. Revenue was up 100.0% from 2026-03-31 to 2026-06-30. RANI currently screens at market cap $41.5M.
NSC currently screens at market cap $60.10B and trailing P/E 18.2. RANI currently screens at market cap $41.5M.
Not investment advice. Open the NSC and RANI stock pages for the full models.
Not investment advice.